Dr. Esha Kaul

July 2011- June 2014: Fellow in Division of Hematology and Oncology, Tufts Medical Center, Boston, MA.

July 2009-June 2011: Resident, Department of Internal Medicine, Tufts Medical Center, Boston, MA.

July 2008-June 2009: Intern, Department of Internal Medicine, Albert Einstein Medical Center, Philadelphia, PA.

February 2007- June 2007: Junior Resident, Department of Employee Health Services, All India Institute of Medical Sciences, New Delhi, India.

August 2001-January 2007: MBBS, All India Institute of Medical Sciences, New Delhi, India.

April 2016-Current: Executive Consultant, Department of Hematology-Oncology/Bone Marrow Transplant, JayPee Hospital, Noida• April 2016-Current: Executive Consultant, Department of Hematology-Oncology/Bone Marrow Transplant, JayPee Hospital, Noida

February 2015-February 2016: Associate Consultant, Department of Hematology- Oncology/Bone Marrow Transplant, BL Kapoor Superspeciality Hospital, New Delhi

2011: American Board of Internal Medicine (ABIM) in Internal Medicine

2014: American Board of Internal Medicine (ABIM) in Hematology

Agarwal N, Pandey P, Kaul E, Dhingra N, Kumar P. Mechanical Cryopreservation of peripheral blood stem cell: Initial experience from a tertiary care hospital. Indian J Hematol Blood Transfus 2019 in print

Chaulagain CP, Sprague KA, Pilichowska M, Cowan J, Klein AK, Kaul E, Miller KB. Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Bone Marrow Transplant. 2019 Apr;54(4):560-566

Kaul E ; Precision medicine in Hematological Malignancies ; Pharma Times, March 2019

Kaul E ; Platelet transfusions: When What and How Much ? ; Management of platelet disorders in clinical practice: UP Journal of Internal Medicine, March 2019

Sehgal T, Singh P, Kaul E ; Stodtmeister Cells (Polymorphs with Pelger-Huët Anomaly) Showing "Faggots" in Mixed Phenotypic Acute Leukemia (T/Myeloid). Indian J Hematol Blood Transfus. 2018 Jan;34(1):148-150

Kaul E, Sharma SK; Multiple Myeloma; Looking beyond standards; Asian Journal of Oncology; Jan-Mar 2016; 2(1) 23-28,

Sharma SK, Choudhary D, Kaul E et al; Hematopoietic Stem Cell Transplant in Elderly Patients:Experience from a Tertiary Care Centre in Northern India ; Indian J Hematol Blood Transfus 2016 Jun; 32(Suppl1) 205-207.

Kaul E , Shah G , Chaulagain C, Comenzo R : Plerixafor and G-CSF for Autologous Stem Cell Mobilization in AL Amyloidosis; BMT ; 2014 Sep;49(9):1233

Kaul E, Pilichowska M, Vullaganti M, Madan N, Comenzo R; Twists and Turns of Determining Amyloid Type and Amyloid-related Organ Damage: Discordance and Clinical Skepticism in the Era of Proteomic Typing. Amyloid, 2014 Mar; 21(1):62-5.

Shah G, Kaul E, Klein A, Miller K, Cossor F, Fallo S, Sprague K, Comenzo R: Open Label Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients with Myeloma or Systemic AL Amyloidosis: A Retrospective Chart Review of Response Rates and Toxicity ; Clinical Therapeutics,2013 October;35(10) 1614-20.

26th March 2019 : Treatment paradigm in FLT3 mutated AML; CME, New Delhi

12th December 2018 ; Clofarabine experience in Adult Leukemias; CME, New Delhi

8th April 2018; Updates in Immune Thrombocytopenic Purpura, 12th National Conference of Medical Fitness Society; New Delhi

16th Clinical Trial Protocol, A Clinical Investigator’s perspective, Indian Society of Clinical Research Workshop

Myelodysplastic Syndrome Mutations: A Breakthrough in Stem Cell Transplant. International Medical Tourism Destination. Addis Ababa , Ethiopia, 20th Feb 2017

Invited Speaker: Clinical Trials: A Clinical Investigator’s Perspective, Indian Society Of Clinical Research Workshop for protocol development, March 2017

EBMT Highlights, 2018 APAC region, May 2018, Chairperson in the session on Lymphoma/Myeloma, Gurgaon,

ASH highlights 2017, Feb 2018, Panelist in the session on Lymphoma/Myeloma, New Delhi

Treating Relapsed Refractory Myeloma in 2017, Myeloma Meet November 2017

Press Conference on World Thalassemia Day, Ghaziabad May 2017

Press Conference on Stem Cell Transplant in Thalassemia , Mathura, August 2017

CME with IMA Moradabad on Stem Cell Therapy: Facts and Myths, June 2017

Invited Speaker at DATRI workshop on Matched Unrelated vs Haploidentical Allogeneic Stem Cell Transplant, Chennai, October 2017

11th Jan 2016: Extracorporeal Photopheresis; from immunosuppression to immunomodulation, CME, New Delhi

28th November 2015; Updates from International Myeloma Workshop, Delhi Hematology Society, New Delhi.

Feb 2015: Extracorporeal Photopheresis in Reduced Intensity Conditioning: 14 Year Follow-up of 206 Patients Reveals an Efficacious Regimen with Low Rates of GVHD. Oral presentation at 2015 BMT tandem meeting; San Diego, CA

April 2014: Plerixafor and G-CSF Moblization for Autologous Stem Cell Transplantation in AL Amyloidosis: Update of a Single Center Experience. International Symposium on Amyloidosis. Indianapolis, Indiana

Kaul E, Dhingra N; Successful Allogenic and Autologous Transplant with Concurrent Usage of Direct-Acting Antivirals for Hepatitis C in Children with Hematological Malignancies, accepted for publication at SIOP 2019

Khandelwal V, Choudhary D, Sharma S, Kharya G, Kaul E, Kothari S, Doval D, Setia R, Handoo A: Haploidentical Hematopoietic Stem Cell Transplant for Thalassaemia Major Using pre transplant immunosupression and Post Transplant Cyclophosphamide; Accepted for presentation at the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation; Valencia, Spain; 2016

Esha Kaul, Sweta Kothari, Rasika Setia, Sanjeev Sharma, Saad Suleiman, Vipin Khandelwal, Gaurav Kharya, Bharti Sharma, Anil Handoo and Dharma Choudhary: Peripheral Blood Stem Cell Collection on Day 4 Is Feasible and Safe in a Majority of Allogeneic Stem Cell Transplant Donors; ASBMT Feb 2016; Honolulu, Abstract #483

Esha Kaul, Sweta Kothari, Rasika Setia, Sanjeev Sharma et al; Day 4 Peripheral Blood Stem Cell Collection in Myeloma Patients is Feasible and and Cost-effective in a Majority of Patients; Abstract presented at the 15th International Myeloma Workshop; September 2015; Rome, Italy; PO#155

Vyas O, Kaul E, Rosenberg A, Shah G, Shah U, Comenzo RL et al.; Splenic Irradiation and a Reduced-Intensity Conditioning Regimen Prior to Allogeneic Stem-Cell Transplantation for Myelofibrosis. Poster presentation at American Society of Hematology meeting December 2014 # 3170

Shah G, Kaul E, Comenzo R. High Response Rates and Minimal Toxicity with Subcutaneous Bortezomib in Combination Regimens in Newly Diagnosed Patients Systemic AL Amyloidosis. International Symposium on Amyloidosis. 2014. Oral presentation

Kaul E , Shah G , Comenzo R; Plerixafor and G-CSF for Autologous Stem Cell Mobilization in AL Amyloidosis: Update of a Single Center Experience; Poster presentation at 2014 BMT Tandem Meetings # 144

Chaulagain C, Sprague K, Klein A, Pilichowska M, Kaul E, Miller K; Squamous Cell Cancers of Head and Neck in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation; Poster presentation at 2014 BMT Tandem Meetings

Shah G, Rosenberg A, Kaul E, Stevenson R, Chin J, Shah U, Dinitz A, Cossor F, Smith H, Klein A, Comenzo R, Miller K, Van Etten R, Siegel R, and Sprague K. Improvement of Blood Glucose Control on the Bone Marrow Transplant (BMT) Unit: A Retrospective Review of Our Quality Improvement Pilot Program. (ASBMT Annual Meeting Abstracts). 2013; # 306.

Kaul E, Flores JP, Paulus J, Gunturu K, Hematology and Oncology; Natural Allies or Time to Part Ways? Results of a Medicine Resident Survey. American Society of Hematology meeting December 2013, Poster # 2920

Kaul E, Shah G, Comenzo R; Plerixafor and G-CSF for Autologous Stem Cell Mobilization in AL Amyloidosis: a Single Center Experience. American Society of Hematology Meeting December 2013, Poster # 4516

Chaulagain C, Kaul E, Miller K; Clinicopathologic Characteristics of Secondary Non- Hematologic Malignancies in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies. Blood,October 2013, Vol 122, 5496

Shah G, Kaul E, Klein A, Miller K, Cossor F, Fallo S, Sprague K, Comenzo R: Subcutaneous Bortezomib, High Response Rate and Low Toxicity: American Society of Hematology meeting December 2012, Poster # 2968

2014: Travel Grant by the International Society of Amyloidosis

2013: Abstract Achievement Award at the ASH meeting December 2013

2005: Institute Book Prize in Pediatrics for being the Best dergraduate at All India Institute of Medical Sciences, New Delhi

2005: Nominated for the Sorel Catherine Freyman gold medal in Pediatrics

2001: Award of Excellence for being in the top 30 students in the country in the Indian National Biology Olympiad

2001: Rank 1 in the All India Armed Forces Medical College entrance Examination

1999: Certificate of Merit and Scholarship awarded for being selected in the National Talent Search Examination held by NCERT, New Delhi

1999: Awarded Certificate of Merit for being among the top 0.1% of successful candidates in English in All India Senior School Certificate Examination

1999: Awarded the Priyaneet Aujla Memorial Award for the Best All Round Student, St. Peter’s Academy

2013: Lecture to Internal Medicine Residents on approach to a patient with anemia.

2012-2014: Lectures to Internal Medicine Residents on introduction to stem cell transplantation.

2012-2013: Moderator for Case Based Discussions for Internal Medicine Resident morning report sessions.

2012-present: Teaching sessions with residents rotating through Hematology and Oncology, including review of peripheral blood smears.

2010-2011: Teaching third and fourth year medical students as senior resident on general medicine service.